IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. (Q46339684)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Laura Airas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

4

Sirpa Jalkanen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Jussi Niemelä

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Igal Ifergan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alexander Prat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

2718-2726

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18825744%20AND%20SRC:MED&resulttype=core&format=json

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

Soluble low-Km 5'-nucleotidase from electric-ray (Torpedo marmorata) electric organ and bovine cerebral cortex is derived from the glycosyl-phosphatidylinositol-anchored ectoenzyme by phospholipase C cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

5′-Nucleotidase: molecular structure and functional aspects

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FEJI.200838437

21 January 2018

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Statins as immunomodulators: comparison with interferon-beta 1b in MS.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

Regulation of Th1 and Th2 lymphocyte migration by human adult brain endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Interferons in relapsing remitting multiple sclerosis: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Focal cerebral ischemia enhances glial expression of ecto-5'-nucleotidase.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Neutrophil-derived 5'-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

CD73/Ecto-5′-Nucleotidase Protects Against Vascular Inflammation and Neointima Formation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

IFN-beta protects from vascular leakage via up-regulation of CD73.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Participation of adenosine receptors in neuroprotection.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Neuroprotective role of adenosine in cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Diminished adenosine A1 receptor expression on macrophages in brain and blood of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Lovastatin enhances ecto-5'-nucleotidase activity and cell surface expression in endothelial cells: implication of rho-family GTPases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Glial cell influence on the human blood-brain barrier

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Migration of multiple sclerosis lymphocytes through brain endothelium.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

TLR signaling tailors innate immune responses in human microglia and astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838437

7 January 2021